Literature DB >> 3512195

Kill kinetics of bacteria under fluctuating concentrations of various antibiotics. II. Description of experiments.

P König, J P Guggenbichler, E Semenitz, W Foisner.   

Abstract

Differences in kill kinetics and regrowth patterns of bacteria under the influence of various antibiotics are frequently not represented by their MIC values. The area under the concentration curve represents antimicrobial activity more accurately than the peak concentration. Readministration of antibiotics should occur prior to bacterial regrowth for optimal efficacy. When administering antibiotics in combinations nonsimultaneous dosing is superior to simultaneous administration.

Mesh:

Substances:

Year:  1986        PMID: 3512195     DOI: 10.1159/000238388

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  8 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Authors:  Markus Mueller; Amparo de la Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

2.  Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics.

Authors:  J G den Hollander; J W Mouton; H A Verbrugh
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  A Diffusion-Based and Dynamic 3D-Printed Device That Enables Parallel in Vitro Pharmacokinetic Profiling of Molecules.

Authors:  Sarah Y Lockwood; Jayda E Meisel; Frederick J Monsma; Dana M Spence
Journal:  Anal Chem       Date:  2016-01-15       Impact factor: 6.986

4.  Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.

Authors:  J G den Hollander; A M Horrevorts; M L van Goor; H A Verbrugh; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

5.  Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro.

Authors:  M L Barclay; E J Begg; S T Chambers; D R Boswell
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Time-survival studies for quantifying effects of azlocillin and tobramycin on Pseudomonas aeruginosa.

Authors:  M M McFarland; E M Scott; A Li Wan Po
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Evaluation of ceftriaxone and other antibiotics against Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pneumoniae under in vitro conditions simulating those of serious infections.

Authors:  G Satta; G Cornaglia; G Foddis; R Pompei
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

8.  Antimicrobial chemotherapy in patients with cystic fibrosis.

Authors:  J P Guggenbichler; J Schneeberger
Journal:  Infection       Date:  1987       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.